DNA-directed alkylating ligands as potential antitumor agents: sequence specificity of alkylation by intercalating aniline mustards.
The sequence preferences for alkylation of a series of novel parasubstituted aniline mustards linked to the DNA-intercalating chromophore 9-aminoacridine by an alkyl chain of variable length were studied by using procedures analogous to Maxam-Gilbert reactions. The compounds alkylate DNA at both guanine and adenine sites. For mustards linked to the acridine by a short alkyl chain through a para O- or S-link group, 5'-GT sequences are the most preferred sites at which N7-guanine alkylation occurs. For analogues with longer chain lengths, the preference of 5'-GT sequences diminishes in favor of N7-adenine alkylation at the complementary 5'-AC sequence. Magnesium ions are shown to selectively inhibit alkylation at the N7 of adenine (in the major groove) by these compounds but not the alkylation at the N3 of adenine (in the minor groove) by the antitumor antibiotic CC-1065. Effects of chromophore variation were also studied by using aniline mustards linked to quinazoline and sterically hindered tert-butyl-9-aminoacridine chromophores. The results demonstrate that in this series of DNA-directed mustards the noncovalent interactions of the carrier chromophores with DNA significantly modify the sequence selectivity of alkylation by the mustard. Relationships between the DNA alkylation patterns of these compounds and their biological activities are discussed.
Prakash
A S
AS
Peter MacCallum Cancer Institute, Melbourne, Victoria, Australia.
Denny
W A
WA
Gourdie
T A
TA
Valu
K K
KK
Woodgate
P D
PD
Wakelin
L P
LP
D000477:Alkylating Agents / Q000494:pharmacology*; D000478:Alkylation; D000816:Aniline Mustard / Q000031:analogs & derivatives; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001483:Base Sequence; D003432:Cross-Linking Reagents / Q000494:pharmacology; D004247:DNA / Q000187:drug effects*; D007364:Intercalating Agents / Q000494:pharmacology*; D008969:Molecular Sequence Data; D009150:Mustard Compounds / Q000494:pharmacology*; D009690:Nucleic Acid Conformation; D013329:Structure-Activity Relationship
D000477:Alkylating Agents; D000970:Antineoplastic Agents; D003432:Cross-Linking Reagents; D007364:Intercalating Agents; D009150:Mustard Compounds; D004247:DNA; D000816:Aniline Mustard